Aortic dissection in a patient treated by sunitinib for metastatic renal cell carcinoma.
Edeline
J
J
Laguerre
B
B
Rolland
Y
Y
Patard
J-J
JJ
D000784:Aortic Dissection / Q000139:chemically induced* / Q000473:pathology; D000959:Antihypertensive Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001014:Aortic Aneurysm / Q000139:chemically induced* / Q000473:pathology; D002292:Carcinoma, Renal Cell / Q000188:drug therapy / Q000556:secondary / Q000601:surgery; D003131:Combined Modality Therapy; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D007211:Indoles / Q000009:adverse effects*; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D008175:Lung Neoplasms / Q000556:secondary; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D009392:Nephrectomy; D011758:Pyrroles / Q000009:adverse effects*; D020123:Sirolimus / Q000031:analogs & derivatives / Q000627:therapeutic use; D000077210:Sunitinib
D000959:Antihypertensive Agents; D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; C401859:temsirolimus; D000077210:Sunitinib; D020123:Sirolimus